Clinical and Translational Research
IntegraGen plays a pivotal role in clinical and translational research by offering a comprehensive suite of genomic services tailored to the needs of healthcare professionals and researchers. The company specializes in high-throughput sequencing, genotyping, and bioinformatics analysis, which are essential for identifying genetic markers associated with various diseases, including cancer and rare genetic disorders. IntegraGen’s services bridge the gap between laboratory discoveries and clinical applications, fostering the development of personalized treatment. strategies and improving patient outcomes. With cutting-edge technology and expertise in genomic data interpretation, IntegraGen advances precision medicine by translating scientific findings into practical healthcare solutions.
Our Services
Genome, Exome, Panel
IntegraGen offers a wide range of DNA sequencing solutions for genomics research.
RNA Seq
RNA-Seq enables the transcriptomic profile of a sample to be obtained by high-throughput sequencing, providing a precise analysis of the expression level of transcripts and their isoforms. IntegraGen has recognized expertise in RNA-Seq, and supports researchers from design to implementation of their expression studies.
Methylation
DNA methylation is one of the most studied epigenetic modifications due to its involvement in numerous diseases such as cancer, neurodegenerative disorders, developmental abnormalities or metabolic diseases such as diabetes. IntegraGen presents an overview of the most innovative and cost-effective sequencing or microarray techniques to guide you in choosing the best method, taking into account the type of project, the region of DNA to be explored, the type of tissue, the quantity and quality of the DNA, as well as your budgetary constraints.
Bioinformatics analysis
IntegraGen offers researchers innovative, customized bioinformatics tools and services to analyze their genomic data.
